GENELL STROBEL

SHERMAN, TX NPI 1194728873

General Payments — all program years on this page

$2,841.33

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 88
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $755.51 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $553.1921
2019 $490.1011
2020 $97.026
2021 $169.806
2022 $217.986
2023 $557.7318
2024 $755.5120

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1084917162 Hologic Sales and Service, LLC $75.68 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089952956 Radius Health, Inc. $23.41 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106173800 ABBVIE INC. $167.65 06/06/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1106173802 ABBVIE INC. $73.75 07/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1111717799 Amgen Inc. $15.34 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111717801 Amgen Inc. $6.71 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111717803 Amgen Inc. $13.46 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111717805 Amgen Inc. $14.45 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111717807 Amgen Inc. $141.08 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128382076 Exact Sciences Corporation $22.62 07/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132304345 SCPHARMACEUTICALS INC. $18.61 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136295563 Organon Llc $26.87 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136295565 Organon Llc $30.39 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139301232 Astellas Pharma US Inc $16.79 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139301264 Astellas Pharma US Inc $13.09 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141757602 Merck Sharp & Dohme LLC $21.78 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141757604 Merck Sharp & Dohme LLC $13.15 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146421905 ASCEND THERAPEUTICS US, LLC $13.88 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150005498 Exeltis, USA Inc. $15.43 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151790399 CVRx, Inc. $31.37 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.